Literature DB >> 17710579

Baroreflex control of sympathetic nerve activity in hypertensive pregnant rats with reduced uterine perfusion.

Tina Hines1, David Beauchamp, Collin Rice.   

Abstract

OBJECTIVE: Baroreflex sensitivity is reduced in women with preeclampsia. The aim of this study was to determine whether baroreflex control of renal sympathetic nerve activity (RSNA) is altered in pregnant rats with reduced uterine perfusion (a model of human preeclampsia).
METHODS: Uterine perfusion was reduced in the third trimester by clipping the distal aorta and uterine branches of the ovarian arteries. RSNA baroreflex parameters were compared at term gestation in rats with reduced uterine perfusion (n = 12), in normal pregnant rats (n = 14) and in nonpregnant rats (n = 14).
RESULTS: Reduced perfusion rats were hypertensive (123.6 +/- 2.3 mm Hg), and normal pregnant rats were hypotensive (97.7 +/- 2.2 mm Hg), compared with controls. In rats with reduced perfusion, the baroreflex was shifted to a higher set-point, and maximum and minimum RSNA were increased compared with normal pregnant rats.
CONCLUSION: The blunted baroreflex gain of normal pregnancy is maintained in rats with reduced uterine perfusion, but a hypertensive shift in baroreflex function exists in this rat model that is associated with a reversal of the reflex maximum and minimum RSNA observed in normal pregnancy.

Entities:  

Mesh:

Year:  2007        PMID: 17710579     DOI: 10.1080/10641950701415598

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  9 in total

Review 1.  Pregnancy and the endocrine regulation of the baroreceptor reflex.

Authors:  Virginia L Brooks; Roger A L Dampney; Cheryl M Heesch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-26       Impact factor: 3.619

2.  Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.

Authors:  Kathryn E Lillegard; Alex C Loeks-Johnson; Jonathan W Opacich; Jenna M Peterson; Ashley J Bauer; Barbara J Elmquist; Ronald R Regal; Jeffrey S Gilbert; Jean F Regal
Journal:  J Pharmacol Exp Ther       Date:  2014-08-22       Impact factor: 4.030

3.  Hypothalamic Paraventricular and Arcuate Nuclei Contribute to Elevated Sympathetic Nerve Activity in Pregnant Rats: Roles of Neuropeptide Y and α-Melanocyte-Stimulating Hormone.

Authors:  Zhigang Shi; Priscila A Cassaglia; Laura C Gotthardt; Virginia L Brooks
Journal:  Hypertension       Date:  2015-10-19       Impact factor: 10.190

Review 4.  Regulation of sympathetic vasomotor activity by the hypothalamic paraventricular nucleus in normotensive and hypertensive states.

Authors:  Roger A Dampney; Lisete C Michelini; De-Pei Li; Hui-Lin Pan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-10       Impact factor: 4.733

5.  Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Heather A Drummond; Babbette LaMarca; Michael J Ryan; Joey P Granger
Journal:  Compr Physiol       Date:  2020-12-09       Impact factor: 9.090

Review 6.  A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model.

Authors:  Jing Li; Babbette LaMarca; Jane F Reckelhoff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

Review 7.  Preeclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of preeclampsia.

Authors:  Omar C Logue; Eric M George; Gene L Bidwell
Journal:  Clin Sci (Lond)       Date:  2016-08-01       Impact factor: 6.124

Review 8.  Adaptations in autonomic nervous system regulation in normal and hypertensive pregnancy.

Authors:  Virginia L Brooks; Qi Fu; Zhigang Shi; Cheryl M Heesch
Journal:  Handb Clin Neurol       Date:  2020

9.  Adrenergic receptor blockade attenuates placental ischemia-induced hypertension.

Authors:  Frank T Spradley; Ying Ge; B Peyton Haynes; Joey P Granger; Christopher D Anderson
Journal:  Physiol Rep       Date:  2018-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.